In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations ...

Healthcare professionals must stop supplying the affected batch, quarantine stock, and return it to suppliers.

Health Canada approves Aflivu, a biosimilar for retinal diseases, enhancing treatment options and affordability for Canadian ...

The VISTA trial is evaluating and comparing 2 dose levels of laru-zova to an untreated control group for the treatment of ...

Boehringer Ingelheim recently announced the start of the THULITE phase II clinical study ( NCT06962839 ). THULITE will ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

EYP-1901 shows promising results in reducing treatment burden for diabetic macular edema, offering sustained improvements in ...

Madhav Vasanthavada, PhD, chief commercial officer and head of business development at Abeona Therapeutics, commented on the agreement, saying, “Beacon’s option exercise further validates AAV204’s ...

As part of the celebration of Ophthalmology Times’ 50th anniversary, Inder Paul Singh, MD, of The Eye Centers of Racine and Kenosha, in Wisconsin, offered a look back at transformative changes in ...

Researchers at Yale School of Medicine have identified in a new study a novel, noninvasive method for diagnosing bacterial corneal ulcers, a serious ophthalmologic condition that can lead to vision ...

Biotechnology company Nanoscope Therapeutics recently announced the formation of Vision Advisory Committee (VAC). 1 VAC is “a group of renowned experts in retina treatment and commercialization,” a ...

ModMed conducted a new survey on 2000 US patients on their comfort with artificial intelligence (AI) use in medical practices. Survey results showed that patients still feel uneasy about AI use in ...